APA (7th ed.) Citation

Rietveld, P. C., Guchelaar, N. A., van Eerden, R. A., de Boer, N. L., de Bruijn, P., Sassen, S. D., . . . Koolen, S. L. (2024). Intraperitoneal pharmacokinetics of systemic oxaliplatin, 5-fluorouracil and bevacizumab in patients with colorectal peritoneal metastases. Biomedicine & Pharmacotherapy, 176, N.PAG. https://doi.org/10.1016/j.biopha.2024.116820

Chicago Style (17th ed.) Citation

Rietveld, Pascale C.S., et al. "Intraperitoneal Pharmacokinetics of Systemic Oxaliplatin, 5-fluorouracil and Bevacizumab in Patients with Colorectal Peritoneal Metastases." Biomedicine & Pharmacotherapy 176 (2024): N.PAG. https://doi.org/10.1016/j.biopha.2024.116820.

MLA (9th ed.) Citation

Rietveld, Pascale C.S., et al. "Intraperitoneal Pharmacokinetics of Systemic Oxaliplatin, 5-fluorouracil and Bevacizumab in Patients with Colorectal Peritoneal Metastases." Biomedicine & Pharmacotherapy, vol. 176, 2024, p. N.PAG, https://doi.org/10.1016/j.biopha.2024.116820.